About CCCN/ Affiliations
In order to provide patients the most progressive and effective cancer treatments, Comprehensive Cancer Centers of Nevada expanded its clinical reach by partnering with some of the world’s most prominent oncology-specialized organizations.In 1995, CCCN physicians became part of The US Oncology Network, one of the largest cancer care service providers with a nationwide network of physicians. For more than 15 years, CCCN has been affiliated with the Johnsson Comprehensive Cancer Center at UCLA, one of the field’s most respected authorities in cancer research and treatment. And since 2003, CCCN has been an affiliate of UCLA’s Translational Oncology Research International network, devoted to evaluating novel agents for the treatment of cancer. CCCN is affiliated with the Community Clinical Oncology Program, which was established by the National Cancer Institute (NCI) to conduct NCI-supported clinical trials and introduce the newest clinical research findings and procedures to the local medical community. CCCN also conducts pediatric oncology research through Children’s Oncology Group.
The US Oncology Network
Comprehensive Cancer Centers of Nevada (CCCN) physicians are part of The US Oncology Network — one of America’s largest cancer-care services provider, with more than 1,100 physicians and 10,000 cancer professionals nationwide who share in the development of clinical research, public policy initiatives and innovative cancer care advancements.
The US Oncology Network conducts clinical research through US Oncology Research, its wholly-owned subsidiary and the nation’s largest community-based cancer research network. US Oncology Research has experienced investigators and dedicated research nurses who specialize in Phase I through Phase IV oncology clinical trials. US Oncology Research serves more than 90 sites in 200 locations managing more than 200 active trials at any given time. The research network has enrolled nearly 47,000 patients in more than 1,100 trials since inception in 1992 and has contributed to the development of 43 cancer therapies approved by the FDA. For more information on US Oncology Research and clinical trial Information, click here.
UCLA’s Jonsson Comprehensive Cancer Center
For more than 15 years, Comprehensive Cancer Centers of Nevada has been affiliated with Jonsson Comprehensive Cancer Center (JCCC) at UCLA, and through the affiliation, patients in Southern Nevada can participate in nationwide, state-of-the-art research trials without leaving their community. JCCC has been designated a comprehensive cancer center by the National Cancer Institute, one of only 40 to receive the gold-star comprehensive status nationwide. The mission of NCI-designated cancer centers is to move basic research discoveries from the laboratory into the clinical setting. In addition, these cancer centers implement outreach programs, which link communities to their research activities and clinical services. JCCC actively sought CCCN to become part of its network of community-based centers for research trials because of the high quality of CCCN’s research physicians. To learn more about Jonsson Comprehensive Cancer Center at UCLA click here.
UCLA’s Translational Oncology Research International
UCLA partners with research institutions, health care providers and companies across the United States in order to offer clinical trials and research studies to patients and volunteers beyond Los Angeles. These TORI (Translational Oncology Research International) investigations offer the same high-quality UCLA standards as campus-based studies. UCLA’s Translational Oncology Research International (TORI) is a clinical oncology research organization devoted to evaluating novel agents for the treatment of cancer. It grew out of the UCLA community oncology network, of which CCCN had been a member since 1996. TORI manages and administers the conduct of clinical research trials for its network of more than 20 centers across the United States. TORI conducts two types of trials: industry-sponsored and TORI’s own investigator-initiated trials.
Community Clinical Oncology Program
The Community Clinical Oncology Program (CCOP) was established by the National Cancer Institute (NCI) in 1983. Through this program, community physicians work with scientists conducting NCI-supported clinical trials. The CCOP introduces the newest clinical research findings and procedures to community settings. CCCN is affiliated with Nevada Cancer Research Foundation, which is a CCOP. Through this affiliation, CCCN oncologists are able to bring the latest cancer procedures and treatments to its patients.
Children’s Oncology Group
The Children’s Oncology Group (COG) is a worldwide clinical trial cooperative group supported by the National Cancer Institute (NCI) and fashioned with the mission of studying childhood cancers. It was formed in 2000 with the merging of four independent cooperative groups; the Children’s Cancer Study Group (CCG), Pediatric Oncology Group (POG), Intergroup Rhabdomyosarcoma Study Group (IRS), and the National Wilms Tumor Study Group (NWTS).